Accumulation of125Iodine Labeled Interleukin-2 in the Pancreas of NOD Mice
- 31 December 2001
- journal article
- Published by Elsevier in Journal of Autoimmunity
- Vol. 17 (4) , 281-287
- https://doi.org/10.1006/jaut.2001.0555
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- New approach for in vivo detection of insulitis in type I diabetes: activated lymphocyte targeting with 123I-labelled interleukin 2Acta Endocrinologica, 1994
- A radiopharmaceutical for imaging areas of lymphocytic infiltration: 123I-interleukin-2. Labelling procedure and animal studiesNuclear Medicine Communications, 1992
- Insulitis in type 1 (insulin‐dependent) diabetes mellitus in man—macrophages, lymphocytes, and interferon‐γ containing cellsThe Journal of Pathology, 1991
- In vivo bio-distribution and metabolism of radiolabelled IL2 in normal and diabetes prone mice: Servizio Speciale Medicina Nucleare, II Clinica Medica, University of Rome “La Sapienza”, ItalyCytokine, 1991
- Type-I Diabetes: A Chronic Autoimmune Disease of Human, Mouse, and RatAnnual Review of Immunology, 1990
- Examination of islets in the pancreas biopsy specimens from newly diagnosed Type 1 (insulin-dependent) diabetic patientsDiabetologia, 1990
- Class-II and IL 2 receptor positive cells in the pancreas of NOD miceDiabetologia, 1987
- DETECTION OF ACTIVATED LYMPHOCYTES IN ENDOCRINE PANCREAS OF BB/W RATS BY INJECTION OF 123I-INTERLEUKIN-2: AN EARLY SIGN OF TYPE 1 DIABETESThe Lancet, 1987
- Labelling of Interleukin-2 (IL-2) with 123-Iodine with Retention of Its Capacity to Bind to Activated LymphocytesExperimental and Clinical Endocrinology & Diabetes, 1987
- Pathologic Anatomy of the Pancreas in Juvenile Diabetes MellitusDiabetes, 1965